The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s MHC Class II agonist, eftilagimod alfa (efti) in combination with MSD’s (Merck & ...

Immutep Limited announces a poster presentation on the TACTI-004 Phase III trial at the European Lung Cancer Congress 2025. Immutep Limited announced an upcoming poster presentation for its ...

Lille and Borussia Dortmund have met infrequently on the European stage, but their encounters have consistently been intriguing. Lille has demonstrated stability in Ligue 1 in recent seasons, ...